HDA Statement on Senate Confirmation of Dr. Robert Califf as FDA Commissioner

February 16, 2022

Arlington, Va. — Healthcare Distribution Alliance (HDA) President and CEO Chester “Chip” Davis, Jr., released the following statement upon the U.S. Senate’s vote to confirm Dr. Robert Califf as FDA Commissioner.

“HDA congratulates Dr. Califf on his confirmation to serve as the FDA Commissioner. Under Dr. Califf’s leadership, HDA and its members look forward to continuing our work alongside the agency to help ensure that lifesaving medicines are available to patients when and where they need them, especially as our nation’s response to COVID-19 evolves and as we work to fully implement the Drug Supply Chain Security Act, a groundbreaking law that will further enhance the safety and efficiency of our nation’s healthcare supply chain.”

About HDA

The Healthcare Distribution Alliance (HDA) represents primary pharmaceutical distributors — the vital link between the nation’s pharmaceutical manufacturers and pharmacies, hospitals, long-term care facilities, clinics and others nationwide. Since 1876, HDA has helped members navigate regulations and innovations to get the right medicines to the right patients at the right time, safely and efficiently. The HDA Research Foundation, HDA’s nonprofit charitable foundation, serves the healthcare industry by providing research and education focused on priority healthcare supply chain issues.